Newsroom
Sorted by: Latest
-
Spectro Cloud and WEKA Partner to Bring Data Closer to AI Workloads, Accelerating Time to Enterprise Value
SAN JOSE, Calif. & CAMPBELL, Calif.--(BUSINESS WIRE)--At NVIDIA GTC, Spectro Cloud and WEKA announced a partnership to simplify and accelerate the deployment of the NVIDIA AI Data Platform, a next-generation reference architecture that integrates NVIDIA‑accelerated computing, networking, and AI-ready storage to deliver high‑throughput, low‑latency data pipelines for AI workloads. The collaboration combines Spectro Cloud’s PaletteAI™ platform for automated, secure AI infrastructure with WEKA’s N...
-
State of Idaho Modernizes Statewide Grant Management with Euna Grants Integration
ATLANTA & TORONTO--(BUSINESS WIRE)--Euna Solutions®, the leading provider of purpose-built cloud solutions for the public sector, today celebrates the State of Idaho’s modernization of its statewide grant management through the deployment of Euna Grants, a cloud-based platform for managing the full grant lifecycle, seamlessly integrated with the state’s enterprise resource planning (ERP) platform. The initiative, led by the Idaho State Controller’s Office, created a connected grant management e...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100® Moderate Buffer UCITS ETF - March 16.03.2026 QMAR.LN IE0006S0EBF2 50,002.00 USD 1,150,471.35 23.009 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Artificial Intelligence UCITS ETF 16.03.2026 FTAI IE000YIQZ0H6 200,002.00 USD 4,552,281.64 22.761 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF- June 16.03.2026 MJUN LN IE000CO3P697 150,002.00 USD 3,728,827.05 24.859 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - December 16.03.2026 QDEC.LN IE000GAKWFA7 450,002.00 USD 10,155,412.63 22.567 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Europe Infrastructure UCITS ETF 16.03.2026 FTEI.LN IE000TIZ5AP4 150,002.00 EUR 3,010,752.76 20.071 ...
-
Universal Fuel Technologies Demonstrates Fully Drop-In Synthetic Aviation Fuel Using HEFA Byproducts
LOS ALTOS, Calif.--(BUSINESS WIRE)--As airlines work to reduce emissions while maintaining operational efficiency with existing aircraft and infrastructure, a critical barrier to 100% sustainable aviation fuel (SAF) adoption has been overcome. Independent testing by Washington State University has validated that Universal Fuel Technologies’ (Unifuel) Flexiforming technology successfully converts HEFA-derived naphtha into synthetic aromatic kerosene that, when blended with paraffinic SAF, create...
-
Doximity Study Finds Physicians Rapidly Adopting AI, But Accuracy Concerns Persist
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released a new report examining how physicians are adopting artificial intelligence (AI) in clinical practice. The findings show that AI adoption and interest are widespread: 94% of physicians reported they are currently using AI or interested in doing so. At the same time, physicians remain cautious, with 71% citing accuracy and reliability as their top concern. “AI h...
-
Alloy Therapeutics Enters Into Agreement to Advance Novel Antibody Discovery Platform
BOSTON--(BUSINESS WIRE)--Alloy Therapeutics, Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting-edge drug discovery technologies, today announced an agreement with AbbVie to develop a new antibody platform to discover potent, specific, and effective antibodies against targets that are difficult to address with current technologies. As part of the multi-year agreement, Alloy will receive an upfront payment, as well as an additional payment in connectio...